Nano-X Imaging Ltd. (NNOX) News
Filter NNOX News Items
NNOX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NNOX News Highlights
- For NNOX, its 30 day story count is now at 16.
- Over the past 29 days, the trend for NNOX's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about NNOX are DRUG, FAT and GE.
Latest NNOX News From Around the Web
Below are the latest news stories about NANO-X IMAGING LTD that investors may wish to consider to help them evaluate NNOX as an investment opportunity.
Why Nanox Stock Skyrocketed 191% in MayShares of medical-imaging start-up company Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, skyrocketed 191.2% in May, according to data provided by S&P Global Market Intelligence. Nanox intends to disrupt the X-ray market with its proprietary imaging technology. Nanox also wants to install machines at little or no cost to medical professionals, charging only a per-use fee. |
2 Medical Imaging Stocks That Are Better Buys Than Nano-XShares of Nano-X Imaging (NASDAQ: NNOX) are up more than 135% to start the year after the company got approval in April from the Food and Drug Administration (FDA) for its Nanox.ARC system. It may be too late to benefit from the stock's rise, but GE HealthCare Technologies (NASDAQ: GEHC) and Lantheus Holdings (NASDAQ: LNTH) are also involved with medical imaging and are less risky plays. The company showed improved revenue in the first quarter, but it is still losing money. |
Is It Too Early to Invest In Nano-X Imaging?It could take years before Nano-X proves there's strong demand for its devices, and even longer to reach profitability. |
Nano-X Imaging Ltd. (NNOX) Just Reclaimed the 20-Day Moving AverageWhen a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react? |
Why Shares of Nano-X Are Soaring WednesdayShares of Nano-X Imaging (NASDAQ: NNOX) were up 10% Wednesday morning, a day after the stock fell below $17 for the first time since May 18. The healthcare company specializes in medical imaging equipment and systems and its shares are up more than 88% so far this year. Nano-X had been surging ever since the company announced on May 1 that it had received clearance from the Food and Drug Administration (FDA) to market Nanox.ARC, including the Nanox.CLOUD, its accompanying cloud-based infrastructure, as a stationary X-ray system on adults. |
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall StreetInvestors looking for growth stocks that can make dramatic moves in a short time should look more closely at healthcare. The phase 2 trial tried four dosage strengths, and even the lowest dose led to liver-fat reduction of 30% or better for a majority of patients. |
Q1 2023 Nano-X Imaging Ltd Earnings CallQ1 2023 Nano-X Imaging Ltd Earnings Call |
Why Nanox Stock Popped Off Another Huge Gain TodayShares of Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, popped off more gains on Monday after the medical imaging device company reported financial results for the first quarter of 2023. As of 3:40 p.m. ET, Nanox stock was up 11%. Nanox is a very early stage company. |
Nano-X Imaging (NNOX) Q1 2023 Earnings Call TranscriptEarlier today, Nano-X Imaging Limited released financial results for the quarter ended March 31, 2023. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call. |
Nanox Announces First Quarter of 2023 Financial Results and Provides Business UpdateReports progress towards global supply chain development Ended the first quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $91.0 million Management to host conference call and webcast Monday, May 22, 2023 at 8:30 AM ET NEVE ILAN, Israel, May 22, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2023 and provid |